Mid Atlantic Financial Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Mid Atlantic Financial Management's BMY Position: Q3 2021 in Review
Mid Atlantic Financial Management reduced its Bristol-Myers Squibb (BMY) stake by 1.2% in Q3 2021, selling an estimated $48.3K and leaving 62,357 shares worth $3.69M. The position accounts for 0.25% of the portfolio, ranked #86.
Mid Atlantic Financial Management first reported a position in BMY in Q4 2018 and has held it in 12 quarters since. The position peaked at $4.22M in Q2 2021. 2,292 funds tracked by Wall St. Rank hold BMY as of Q3 2021.
- Mid Atlantic Financial Management held 62,357 shares of Bristol-Myers Squibb worth $3.69M as of Q3 2021.
- Mid Atlantic Financial Management sold 733 Bristol-Myers Squibb shares in Q3 2021, an estimated $48.3K.
- Bristol-Myers Squibb made up 0.25% of Mid Atlantic Financial Management's portfolio in Q3 2021, its #86 holding.
- Mid Atlantic Financial Management first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 12 quarters since.
- Mid Atlantic Financial Management's Bristol-Myers Squibb position peaked at $4.22M in Q2 2021.
- 2,292 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2021.
Based on Mid Atlantic Financial Management's 13F filing for Q3 2021, filed 12 Nov 2021.